Your browser doesn't support javascript.
loading
Collagen IVα345 dysfunction in glomerular basement membrane diseases. I. Discovery of a COL4A3 variant in familial Goodpasture's and Alport diseases.
Pokidysheva, Elena N; Seeger, Harald; Pedchenko, Vadim; Chetyrkin, Sergei; Bergmann, Carsten; Abrahamson, Dale; Cui, Zhao Wei; Delpire, Eric; Fervenza, Fernando C; Fidler, Aaron L; Fogo, Agnes B; Gaspert, Ariana; Grohmann, Maik; Gross, Oliver; Haddad, George; Harris, Raymond C; Kashtan, Clifford; Kitching, A Richard; Lorenzen, Johan M; McAdoo, Stephen; Pusey, Charles D; Segelmark, Marten; Simmons, Alicia; Voziyan, Paul A; Wagner, Timo; Wüthrich, Rudolf P; Zhao, Ming-Hui; Boudko, Sergei P; Kistler, Andreas D; Hudson, Billy G.
Afiliação
  • Pokidysheva EN; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Seeger H; Nephrology Division, University Hospital Zurich, Zurich, Switzerland.
  • Pedchenko V; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Chetyrkin S; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Bergmann C; Department of Medicine and Nephrology, University Hospital Freiburg, Freiburg, Germany; Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.
  • Abrahamson D; Department of Anatomy and Cell Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
  • Cui ZW; Renal Division, Peking University First Hospital, Beijing, PR China.
  • Delpire E; Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Fervenza FC; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Fidler AL; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Aspirnaut Program, Vanderbilt University Medical Center, Nashville, Tennessee,
  • Fogo AB; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Gaspert A; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
  • Grohmann M; Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.
  • Gross O; Clinic of Nephrology and Rheumatology, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
  • Haddad G; Nephrology Division, University Hospital Zurich, Zurich, Switzerland.
  • Harris RC; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kashtan C; Division of Pediatric Nephrology, University of Minnesota Medical School and Masonic Children's Hospital, Minneapolis, Minnesota, USA.
  • Kitching AR; Centre for Inflammatory Diseases, Monash University Department Medicine, Nephrology, Monash Health, Clayton, VIC, Australia.
  • Lorenzen JM; Nephrology Division, University Hospital Zurich, Zurich, Switzerland.
  • McAdoo S; Centre for Inflammatory Disease, Imperial College London, London, UK.
  • Pusey CD; Centre for Inflammatory Disease, Imperial College London, London, UK.
  • Segelmark M; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
  • Simmons A; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Aspirnaut Program, Vanderbilt University Medical Center, Nashville, Tennessee,
  • Voziyan PA; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Wagner T; Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.
  • Wüthrich RP; Nephrology Division, University Hospital Zurich, Zurich, Switzerland.
  • Zhao MH; Renal Division, Peking University First Hospital, Beijing, PR China.
  • Boudko SP; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biochemistry, Vanderbilt University, Nashville, Tennessee, USA.
  • Kistler AD; Department of Internal Medicine, Kantonsspital Frauenfeld, Frauenfeld, Switzerland.
  • Hudson BG; Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Center for Matrix Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Aspirnaut Program, Vanderbilt University Medical Center, Nashville, Tennessee,
J Biol Chem ; 296: 100590, 2021.
Article em En | MEDLINE | ID: mdl-33774048

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Antimembrana Basal Glomerular / Colágeno Tipo IV / Mutação / Nefrite Hereditária Limite: Animals Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Antimembrana Basal Glomerular / Colágeno Tipo IV / Mutação / Nefrite Hereditária Limite: Animals Idioma: En Revista: J Biol Chem Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos